Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Checkpoint Therapeutics, Inc. (CKPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 80,906 shares
@ $0 |
|
| 07/03/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 81,406 shares
@ $0 |
|
| 06/15/2023 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 06/15/2023 |
4
| SALZMAN BARRY M (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 06/15/2023 |
4
| ROSENWALD LINDSAY A MD (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 06/15/2023 |
4
| Herskowitz Neil (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 06/15/2023 |
4
| Boilen Scott (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 06/15/2023 |
4
| Bechon Christian (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 17,483 shares
@ $0 |
|
| 04/04/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 250,000 shares
@ $0 |
|
| 04/04/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 04/04/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 35,714 shares
@ $0
Granted 42,500 shares
@ $0 |
|
| 03/03/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 5,548 shares
@ $4.65, valued at
$25.8k
Granted 15,000 shares
@ $0
Sold 5,483 shares
@ $5, valued at
$27.4k
|
|
| 03/03/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 1,914 shares
@ $4.66, valued at
$8.9k
Granted 7,500 shares
@ $0
Sold 3,591 shares
@ $5, valued at
$18k
|
|
| 02/03/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 3,154 shares
@ $4.79, valued at
$15.1k
|
|
| 02/03/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 10,261 shares
@ $4.77, valued at
$48.9k
|
|
| 01/12/2023 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 1,858 shares
@ $6.749, valued at
$12.5k
|
|
| 01/12/2023 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 3,817 shares
@ $6.749, valued at
$25.8k
|
|
| 01/06/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 368,907 shares
@ $0 |
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Boilen Scott (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 47,619 shares
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| SALZMAN BARRY M (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 47,619 shares
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 302,777 shares
@ $3.11, valued at
$941.6k
Paid exercise price by delivering 53,024 shares
@ $2.77, valued at
$146.9k
Paid exercise price by delivering 143,136 shares
@ $2.19, valued at
$313.5k
Paid exercise price by delivering 31,972 shares
@ $2.46, valued at
$78.7k
Paid exercise price by delivering 117,657 shares
@ $1.85, valued at
$217.7k
Sold 86,353 shares
@ $1.79, valued at
$154.6k
Sold 14,030 shares
@ $1.77, valued at
$24.8k
Sold 21,258 shares
@ $1.51, valued at
$32.1k
|
|
| 03/11/2022 |
4
| GRAY WILLIAM GARRETT (CFO) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Sold 38,197 shares
@ $1.893, valued at
$72.3k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Boilen Scott (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 16,502 shares
@ $0 |
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| SALZMAN BARRY M (Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.|
Txns:
| Granted 16,502 shares
@ $0 |
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|